1984
DOI: 10.1001/archderm.120.10.1344
|View full text |Cite
|
Sign up to set email alerts
|

beta-Galactosidase and neuraminidase deficiency associated with angiokeratoma corporis diffusum

Abstract: A 17-year-old Japanese boy was found to have ataxia, generalized angiokeratomas, skeletal deformities, visual impairment, and macular cherry-red spots, without hepatomegaly, splenomegaly, or renal failure. Laboratory examination disclosed a deficiency of beta-galactosidase as well as of neuraminidase activity in the leukocytes and fibroblasts, while alpha-galactosidase and alpha-L-fucosidase activities were normal. On electron microscopic examination, numerous cytoplasmic vacuoles containing flocculated materi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1985
1985
2007
2007

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Angiokeratoma corporis diffusum is one of the most characteristic manifestations of lysosomal storage diseases such as Fabry’s disease, fucosidosis type II [1], GM1 gangliosidosis type I [2], β-mannosidase deficiency [3] and galactosialidosis [4], as well as in patients with normal enzyme activities [5]. Galactosialidosis is a recently identified genetic lysosomal storage disease characterized by the combined deficiency of β-galactosidase and neuramidase activity [6, 7] due to the lack of a 32-kD ‘protective protein’ that is crucial for the biological activity of these two enzymes [8].…”
Section: Introductionmentioning
confidence: 99%
“…Angiokeratoma corporis diffusum is one of the most characteristic manifestations of lysosomal storage diseases such as Fabry’s disease, fucosidosis type II [1], GM1 gangliosidosis type I [2], β-mannosidase deficiency [3] and galactosialidosis [4], as well as in patients with normal enzyme activities [5]. Galactosialidosis is a recently identified genetic lysosomal storage disease characterized by the combined deficiency of β-galactosidase and neuramidase activity [6, 7] due to the lack of a 32-kD ‘protective protein’ that is crucial for the biological activity of these two enzymes [8].…”
Section: Introductionmentioning
confidence: 99%
“…ACD is considered a cutaneous hallmark of Andersone Fabry disease; however, certain other lysosomal storage diseases, including b-mannosidosis, are also characterized by ACD (Table I). [17][18][19][20][21][22][23][24] Ultrastructural examination of these angiokeratomas reveals lysosomal substrate deposition that differs in the fine structural appearance of the respective storage material. In AndersoneFabry disease, electron dense lysosomal granules are observed in the cytoplasm by electron microscopy, whereas in b-mannosidosis storage vacuoles are seen.…”
mentioning
confidence: 99%